127 related articles for article (PubMed ID: 25394912)
1. Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients.
Beer L; Valverde EE; Raiford JL; Weiser J; White BL; Skarbinski J
J Int Assoc Provid AIDS Care; 2015; 14(3):245-54. PubMed ID: 25394912
[TBL] [Abstract][Full Text] [Related]
2. Systemic Delays in the Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients in Houston, Texas: The Providers' Report Card.
Mgbere O; Rodriguez-Barradas M; Vigil KJ; McNeese M; Tabassam F; Barahmani N; Wang J; Arafat R; Essien EJ
J Int Assoc Provid AIDS Care; 2018; 17():2325958218774042. PubMed ID: 29745311
[TBL] [Abstract][Full Text] [Related]
3. Trends in provider-advised HIV antiretroviral therapy deferral in the United States, 2009-2014.
Beer L; Weiser J; Luke Shouse R
AIDS Care; 2019 Jul; 31(7):821-826. PubMed ID: 30466314
[TBL] [Abstract][Full Text] [Related]
4. Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.
Westergaard RP; Ambrose BK; Mehta SH; Kirk GD
J Int AIDS Soc; 2012 Feb; 15(1):10. PubMed ID: 22360788
[TBL] [Abstract][Full Text] [Related]
5. Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians.
Krakower DS; Beekmann SE; Polgreen PM; Mayer KH
Clin Infect Dis; 2016 Jan; 62(1):99-105. PubMed ID: 26385993
[TBL] [Abstract][Full Text] [Related]
6. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
Suárez-García I; González J; Berenguer J; García F; Portilla J; Muga R; Moreno S; Jarrín I;
Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):580-587. PubMed ID: 30982676
[TBL] [Abstract][Full Text] [Related]
7. Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.
Hoehn N; Gill MJ; Krentz HB
AIDS Care; 2017 May; 29(5):564-569. PubMed ID: 27642701
[TBL] [Abstract][Full Text] [Related]
8. An investigation of why eligible patients do not receive HAART.
Maisels L; Steinberg J; Tobias C
AIDS Patient Care STDS; 2001 Apr; 15(4):185-91. PubMed ID: 11359660
[TBL] [Abstract][Full Text] [Related]
9. Physician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, Russia.
Vetrova MV; Aleksandrova OV; Paschenko AE; Toropov SE; Rassokhin VV; Abyshev RA; Levina OS; Niccolai L; Heimer R
AIDS Care; 2021 Apr; 33(4):473-477. PubMed ID: 32148065
[TBL] [Abstract][Full Text] [Related]
10. Prevention counseling practices of HIV care providers with patients new to HIV medical care: medical monitoring project provider survey, 2009.
Valverde E; Beer L; Johnson C; Blair JM; Mattson CL; Sanders C; Weiser J; Skarbinski J
J Int Assoc Provid AIDS Care; 2014; 13(2):127-34. PubMed ID: 24429103
[TBL] [Abstract][Full Text] [Related]
11. [Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study].
Viciana-Fernández P; Falcó V; Castaño M; de los Santos-Gil I; Olalla-Sierra J; Hernando A; Deig E; Clotet B; Knobel H; Podzamczer D; Pedrol PD;
Enferm Infecc Microbiol Clin; 2015; 33(6):397-403. PubMed ID: 25577557
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.
Wang X; Wu Z
AIDS; 2007 Dec; 21 Suppl 8():S149-55. PubMed ID: 18172384
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
[TBL] [Abstract][Full Text] [Related]
14. Delivery of HIV Antiretroviral Therapy Adherence Support Services by HIV Care Providers in the United States, 2013 to 2014.
Weiser J; Beer L; Brooks JT; Irwin K; West BT; Duke CC; Gremel GW; Skarbinski J
J Int Assoc Provid AIDS Care; 2017; 16(6):624-631. PubMed ID: 28899259
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients.
Campo RE; Narayanan S; Clay PG; Dehovitz J; Johnson D; Jordan W; Squires KE; Sajjan SG; Markson LE
AIDS Patient Care STDS; 2007 May; 21(5):329-38. PubMed ID: 17518525
[TBL] [Abstract][Full Text] [Related]
16. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
[TBL] [Abstract][Full Text] [Related]
17. Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.
Barfod TS; Hecht FM; Rubow C; Gerstoft J
BMC Health Serv Res; 2006 Dec; 6():154. PubMed ID: 17144910
[TBL] [Abstract][Full Text] [Related]
18. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study.
Kumarasamy N; Safren SA; Raminani SR; Pickard R; James R; Krishnan AK; Solomon S; Mayer KH
AIDS Patient Care STDS; 2005 Aug; 19(8):526-37. PubMed ID: 16124847
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence adherence to HIV medications: perceptions of women and health care providers.
Abel E; Painter L
J Assoc Nurses AIDS Care; 2003; 14(4):61-9. PubMed ID: 12953613
[TBL] [Abstract][Full Text] [Related]
20. Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA.
Schneider G; Juday T; Wentworth C; Lanes S; Hebden T; Seekins D
AIDS Care; 2013; 25(11):1470-6. PubMed ID: 23517139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
